Coronavirus disease 2019-associated rapidly progressive organizing pneumonia with fibrotic feature: Two case reports

Medicine (Baltimore). 2020 Aug 28;99(35):e21804. doi: 10.1097/MD.0000000000021804.

Abstract

Introduction: Pneumonia is one of the most important characteristics of coronavirus disease 2019 (COVID-19) and imaging findings of COVID-19 pneumonia are diverse and change over disease course. However, the detailed clinical course of organizing pneumonia (OP) caused by COVID-19 has not been clarified.

Patient concerns: A 60-year-old man and a 61-year-old woman diagnosed with mild COVID-19 were admitted to our hospital. Their respiratory symptoms were deteriorating even after initiating treatment with antiviral drugs.

Diagnosis: Chest X-rays and computed tomography scan showed a rapid progression of linear consolidation with reversed halo sign, distributed in subpleural and peri-bronchial regions. They also presented with pulmonary fibrosis findings, including traction bronchiectasis and marked lung volume reduction. They were diagnosed with rapidly progressing OP.

Interventions: They were treated with systemic corticosteroids.

Outcomes: The patients' imaging findings and respiratory conditions improved rapidly without any adverse effects.

Conclusion: Physicians should carefully monitor patients with COVID-19, as they can develop rapidly progressive and fibrotic OP, which respond to corticosteroids.

Publication types

  • Case Reports

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19
  • Coronavirus Infections* / complications
  • Coronavirus Infections* / physiopathology
  • Coronavirus Infections* / therapy
  • Disease Progression
  • Dose-Response Relationship, Drug
  • Female
  • Glucocorticoids / administration & dosage
  • Humans
  • Lung* / diagnostic imaging
  • Lung* / pathology
  • Male
  • Middle Aged
  • Pandemics*
  • Pneumonia, Viral* / complications
  • Pneumonia, Viral* / diagnosis
  • Pneumonia, Viral* / etiology
  • Pneumonia, Viral* / physiopathology
  • Pneumonia, Viral* / therapy
  • Prednisolone / administration & dosage*
  • Pulmonary Fibrosis* / diagnostic imaging
  • Pulmonary Fibrosis* / etiology
  • Tomography, X-Ray Computed / methods
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Glucocorticoids
  • Prednisolone